Covid US: Pfizer tests combination booster and pneumococcal vaccine on elderly
Pfizer began a new study on Monday as they work towards creating a vaccine booster shot Study includes 600 people 65 or older who will be given a combination of the vaccine booster and a vaccine to prevent pneumococcal bacteria Pneumococcal vaccines are believed to be effective against COVID-19 Third shot of the vaccine could be needed as early as September for some Americans
Source: dailymail.co.uk